Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells
Epithelial ovarian cancer (EOC) is the deadliest tumor among gynecological cancer in the industrialized countries. The EOC incidence and mortality have remained unchanged over the last 30 years, despite the progress in diagnosis and treatment. In order to develop novel and more effective therapeutic...
Main Authors: | Francesca Roggiani, Delia Mezzanzanica, Katia Rea, Antonella Tomassetti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/9/1387 |
Similar Items
-
Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth
by: Katia Rea, et al.
Published: (2018-07-01) -
Integrins and Cadherins as Therapeutic Targets in Fibrosis
by: Sandeep Krishna Agarwal
Published: (2014-06-01) -
The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors
by: Bozhkova Desislava M., et al.
Published: (2019-06-01) -
The role of the cell adhesion molecules (integrins / cadherins) in prostate cancer
by: Alexandros Drivalos, et al.
Published: (2011-06-01) -
N-cadherin and integrin blockade inhibit arteriolar myogenic reactivity but not pressure-induced increases in intracellular Ca2+
by: Teresa Y. Jackson, et al.
Published: (2010-12-01)